High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment.  Campusano C, Kanner R, McDonell C, Morris M, Duarte M, Price JC.  Harm Reduct J. 2024 Jan 29;21(1):25. doi: 10.118…

Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs We are excited to launch Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs! The publication is part of C-EHR…

Late presentation for hepatitis C treatment: prevalence and risk factors in the Swiss Hepatitis C Cohort.  Brunner, Nathalie; Grischott, Thomas; Bruggmann, Philip;the Swiss Hepatitis C Cohort Study Group.  European Journal of Gastroenter…

A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national data.  McDonald SA, Hickma…

Hepatitis C in pregnancy.  Lange M, Schmidt N, Kushner T.  Clin Liver Dis (Hoboken). 2023 Nov 29;22(6):200-205. doi: 10.1097/CLD.0000000000000093. PMID: 38143816; PMCID: PMC10745245. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10745245/

Point-of-Care Testing for Hepatitis Viruses: A Growing Need.  Pauly MD, Ganova-Raeva L.  Life (Basel). 2023 Nov 28;13(12):2271. doi: 10.3390/life13122271. PMID: 38137872; PMCID: PMC10744957. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC…